Page 200 - Haematologica May 2020

B. Mariotti et al.
lymphocytic leukemia. N Engl J Med. 2012;
366(20):1905-1913.
8. Qiu ZY, Fan L, Wang L, et al. STAT3 muta-
tions are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia. J Hematol Oncol. 2013;6:82.
9. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP, Jr. Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood. 1998;92(12):4771-4777.
10. Liu JH, Wei S, Lamy T, et al. Chronic neu- tropenia mediated by fas ligand. Blood. 2000;95(10):3219-3222.
11. Perzova R, Loughran TP, Jr. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol. 1997; 97(1):123-126.
12. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nat Med. 1996;2(3):317- 322.
13. Ikeda S, Tagawa H. Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias. Int J Hematol. 2014; 99(5):542-552.
14. Lawrie CH. MicroRNAs in hematological malignancies. Blood Rev. 2013;27(3):143- 154.
15. Gattazzo C, Teramo A, Passeri F, et al. Detection of monoclonal T populations in patients with KIR-restricted chronic lym- phoproliferative disorder of NK cells. Haematologica. 2014;99(12):1826-1833.
16. Teramo A, Gattazzo C, Passeri F, et al. Intrinsic and extrinsic mechanisms con- tribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood. 2013;121(19): 3843-3854, S1.
17. Bazzoni F, Rossato M, Fabbri M, et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A. 2009;106(13):5282- 5287.
18. Rossato M, Cencig S, Gasperini S, Cassatella
MA, Bazzoni F. IL-10 modulates cytokine gene transcription by protein synthesis-inde- pendent and dependent mechanisms in lipopolysaccharide-treated neutrophils. Eur J Immunol. 2007;37(11):3176-3189.
19. Mohn F, Weber M, Schubeler D, Roloff TC. Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol. 2009;507:55- 64.
20. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798- 809.
21. Lee H, Deng J, Xin H, Liu Y, Pardoll D, Yu H. A requirement of STAT3 DNA binding pre- cludes Th-1 immunostimulatory gene expression by NF-kappaB in tumors. Cancer Res. 2011;71(11):3772-3780.
22. Niu G, Wright KL, Ma Y, et al. Role of Stat3 in regulating p53 expression and function. Mol Cell Biol. 2005;25(17):7432-7440.
23. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3- and DNA methyltransferase 1-mediated epige- netic silencing of SHP-1 tyrosine phos- phatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A. 2005;102(19):6948-6953.
24. Curtale G, Mirolo M, Renzi TA, Rossato M, Bazzoni F, Locati M. Negative regulation of Toll-like receptor 4 signaling by IL-10- dependent microRNA-146b. Proc Natl Acad Sci U S A. 2013;110(28):11499-11504.
25. Renzi TA, Rubino M, Gornati L, Garlanda C, Locati M, Curtale G. MiR-146b Mediates Endotoxin Tolerance in Human Phagocytes. Mediators Inflamm. 2015;2015:145305.
26. Villela D, Ramalho RF, Silva AR, et al. Differential DNA Methylation of MicroRNA Genes in Temporal Cortex from Alzheimer's Disease Individuals. Neural Plast. 2016;2016:2584940.
27. Xiang M, Birkbak NJ, Vafaizadeh V, et al. STAT3 induction of miR-146b forms a feed- back loop to inhibit the NF-kappaB to IL-6 signaling axis and STAT3-driven cancer phe- notypes. Sci Signal. 2014;7(310):ra11.
28. Saitoh T, Karasawa M, Sakuraya M, et al. Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas lig- and is a marker of LGL leukemia activity. Eur J Haematol. 2000;65(4):272-275.
29. Drury GL, Di Marco S, Dormoy-Raclet V, Desbarats J, Gallouzi IE. FasL expression in activated T lymphocytes involves HuR- mediated stabilization. J Biol Chem. 2010; 285(41):31130-31138.
30. Cheng HS, Sivachandran N, Lau A, et al. MicroRNA-146 represses endothelial activa- tion by inhibiting pro-inflammatory path- ways. EMBO Mol Med. 2013;5(7):1017- 1034.
31. YangW,YuH,ShenY,LiuY,YangZ,SunT. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/beta- catenin pathway. Oncotarget. 2016;7(27): 41505-41526.
32. Clemente MJ, Przychodzen B, Jerez A, et al. Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lympho- cyte leukemia identifies signature land- scapes. Blood. 2013;122(25):4077-4085.
33. Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyl- transferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108(3):1058-1064.
34. Mishra A, Liu S, Sams GH, et al. Aberrant overexpression of IL-15 initiates large granu- lar lymphocyte leukemia through chromo- somal instability and DNA hypermethyla- tion. Cancer Cell. 2012;22(5):645-655.
35. Gattazzo C, Teramo A, Miorin M, et al. Lack of expression of inhibitory KIR3DL1 recep- tor in patients with natural killer cell-type lymphoproliferative disease of granular lym- phocytes. Haematologica. 2010;95(10):1722- 1729.
36. Zhu H, Berkova Z, Mathur R, et al. HuR Suppresses Fas Expression and correlates with patient outcome in liver cancer. Mol Cancer Res. 2015;13(5):809-818.
1360
haematologica | 2020; 105(5)